788 related articles for article (PubMed ID: 19392907)
21. Comparing overdose mortality associated with methadone and buprenorphine treatment.
Bell JR; Butler B; Lawrance A; Batey R; Salmelainen P
Drug Alcohol Depend; 2009 Sep; 104(1-2):73-7. PubMed ID: 19443138
[TBL] [Abstract][Full Text] [Related]
22. Syncope and QT prolongation among patients treated with methadone for heroin dependence in the city of Copenhagen.
Fanoe S; Hvidt C; Ege P; Jensen GB
Heart; 2007 Sep; 93(9):1051-5. PubMed ID: 17344330
[TBL] [Abstract][Full Text] [Related]
23. Mortality among opiate users: opioid maintenance therapy, age and causes of death.
Clausen T; Waal H; Thoresen M; Gossop M
Addiction; 2009 Aug; 104(8):1356-62. PubMed ID: 19426288
[TBL] [Abstract][Full Text] [Related]
24. Electrocardiogram characteristics of methadone and buprenorphine maintained subjects.
Athanasos P; Farquharson AL; Compton P; Psaltis P; Hay J
J Addict Dis; 2008; 27(3):31-5. PubMed ID: 18956527
[TBL] [Abstract][Full Text] [Related]
25. Heterogeneous impact of methadone on the QTc interval: what are the practical implications?
Krantz MJ
J Addict Dis; 2008; 27(4):5-9. PubMed ID: 19042586
[TBL] [Abstract][Full Text] [Related]
26. Mortality related to pharmacotherapies for opioid dependence: a comparative analysis of coronial records.
Gibson AE; Degenhardt LJ
Drug Alcohol Rev; 2007 Jul; 26(4):405-10. PubMed ID: 17564876
[TBL] [Abstract][Full Text] [Related]
27. Frequency and prognostic significance of QT prolongation in chronic renal failure patients.
Voiculescu M; Ionescu C; Ismail G
Rom J Intern Med; 2006; 44(4):407-17. PubMed ID: 18386617
[TBL] [Abstract][Full Text] [Related]
28. [Routine ECG in methadone-assisted rehabilitation is wrong prioritization].
Krook AL; Waal H; Hansteen V
Tidsskr Nor Laegeforen; 2004 Nov; 124(22):2940-1. PubMed ID: 15550974
[TBL] [Abstract][Full Text] [Related]
29. Induction of patients with moderately severe methadone dependence onto buprenorphine.
Glasper A; Reed LJ; de Wet CJ; Gossop M; Bearn J
Addict Biol; 2005 Jun; 10(2):149-55. PubMed ID: 16191667
[TBL] [Abstract][Full Text] [Related]
30. Long-term consequences of acute pain for patients under methadone or buprenorphine maintenance treatment.
Bounes V; Palmaro A; Lapeyre-Mestre M; Roussin A
Pain Physician; 2013; 16(6):E739-47. PubMed ID: 24284855
[TBL] [Abstract][Full Text] [Related]
31. Opioid maintenance treatment during pregnancy: occurrence and severity of neonatal abstinence syndrome. A national prospective study.
Bakstad B; Sarfi M; Welle-Strand GK; Ravndal E
Eur Addict Res; 2009; 15(3):128-34. PubMed ID: 19332991
[TBL] [Abstract][Full Text] [Related]
32. Treatment retention in adolescent patients treated with methadone or buprenorphine for opioid dependence: a file review.
Bell J; Mutch C
Drug Alcohol Rev; 2006 Mar; 25(2):167-71. PubMed ID: 16627307
[TBL] [Abstract][Full Text] [Related]
33. One-year mortality rates of patients receiving methadone and buprenorphine maintenance therapy: a nationally representative cohort study in 2694 patients.
Soyka M; Apelt SM; Lieb M; Wittchen HU
J Clin Psychopharmacol; 2006 Dec; 26(6):657-60. PubMed ID: 17110826
[TBL] [Abstract][Full Text] [Related]
34. Neuropsychological functioning of opiate-dependent patients: a nonrandomized comparison of patients preferring either buprenorphine or methadone maintenance treatment.
Loeber S; Kniest A; Diehl A; Mann K; Croissant B
Am J Drug Alcohol Abuse; 2008; 34(5):584-93. PubMed ID: 18720267
[TBL] [Abstract][Full Text] [Related]
35. QTc interval prolongation for patients in methadone maintenance treatment: a five years follow-up study.
Fareed A; Vayalapalli S; Scheinberg K; Gale R; Casarella J; Drexler K
Am J Drug Alcohol Abuse; 2013 Jul; 39(4):235-40. PubMed ID: 23808912
[TBL] [Abstract][Full Text] [Related]
36. Measurement of QTc in patients receiving chronic methadone therapy.
Cruciani RA; Sekine R; Homel P; Lussier D; Yap Y; Suzuki Y; Schweitzer P; Yancovitz SR; Lapin JA; Shaiova L; Sheu RG; Portenoy RK
J Pain Symptom Manage; 2005 Apr; 29(4):385-91. PubMed ID: 15857742
[TBL] [Abstract][Full Text] [Related]
37. Prevalence of QTc prolongation in adult Nigerians with chronic heart failure.
Kolo PM; Opadijo OG; Omotoso AB; Balogun MO; Araoye MA; Katibi IA
West Afr J Med; 2008 Apr; 27(2):69-73. PubMed ID: 19025017
[TBL] [Abstract][Full Text] [Related]
38. Effect of arsenic trioxide on QT interval in patients with advanced malignancies.
Barbey JT; Pezzullo JC; Soignet SL
J Clin Oncol; 2003 Oct; 21(19):3609-15. PubMed ID: 14512391
[TBL] [Abstract][Full Text] [Related]
39. Patients' help-seeking behaviours for health problems associated with methadone and buprenorphine treatment.
Winstock AR; Lea T; Sheridan J
Drug Alcohol Rev; 2008 Jul; 27(4):393-7. PubMed ID: 18584389
[TBL] [Abstract][Full Text] [Related]
40. Dispersion of the corrected QT and JT interval in the electrocardiogram of alcoholic patients.
Corović N; Duraković Z; Misigoj-Duraković M
Alcohol Clin Exp Res; 2006 Jan; 30(1):150-4. PubMed ID: 16433743
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
